Doctor profile · Federal record
Dr. Etleva Bejko, M.D.
Rheumatology Physician (CMS: Rheumatology) · Vista, CA
- NPI 1164804431
- Accepts Medicare
- MIPS 96.8 / 100 · 2023
- 6 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2023 W Vista Way Ste H
Vista, CA 920836030
(760) 724-5800
Credentials & registration
- NPI registered
- June 2015 — 11 yrs on file
- Profile last updated
- February 7, 2023
- Year of graduation
- 2020 — 6 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- California #A169155
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1164804431. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
97,789
Distinct HCPCS
10
Medicare allowed
$1,106,220
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 67,200 | 22 | $5 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 14,700 | 17 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 6,541 | 69 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 2,450 | 14 | $33 | |
Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 2,320 | 14 | $41 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,186 | 102 | $1 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 960 | 334 | $139 | |
J3304 |
Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 866 | 18 | $17 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 312 | 57 | $85 | |
20610 |
Aspiration and/or injection of fluid from large joint | 289 | 92 | $73 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 3,857. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$1,141
Transactions
43
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 12 | $157.28 | |
| ABBVIE INC. | 6 | $139.75 | |
| Janssen Scientific Affairs, LLC | 1 | $138.37 | |
| DePuy Synthes Sales Inc. | 5 | $106.91 | |
| Amgen Inc. | 3 | $95.81 | |
| Novartis Pharmaceuticals Corporation | 3 | $84.14 | |
| Mallinckrodt Hospital Products Inc. | 2 | $74.39 | |
| AstraZeneca Pharmaceuticals LP | 3 | $67.09 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $61.90 | |
| Organon Llc | 1 | $32.66 | |
| Zimmer Biomet Holdings, Inc. | 1 | $29.19 | |
| Fresenius Kabi USA, LLC | 1 | $27.83 | |
| Radius Health, Inc. | 1 | $24.31 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $23.15 | |
| Aurinia Pharma U.S., Inc. | 1 | $21.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,691
Patients
454
Total drug cost
$807,406
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 305 | 67 | $15,747 |
| Prednisone | Generic | 280 | 78 | $2,959 |
| Methotrexate (Methotrexate Sodium) | Brand | 246 | 63 | $10,994 |
| Gabapentin | Generic | 178 | 52 | $2,278 |
| Duloxetine Hcl | Generic | 97 | 30 | $2,309 |
| Methylprednisolone | Generic | 78 | 43 | $622 |
| Allopurinol | Generic | 75 | 18 | $1,502 |
| Humira(Cf) Pen (Adalimumab) | Brand | 72 | 0 | $761,733 |
| Tramadol Hcl | Generic | 67 | 15 | $491 |
| Celecoxib | Generic | 62 | 22 | $3,493 |
Hospital affiliations
Frequently asked questions
What is Dr. Etleva Bejko's medical specialty?
Dr. Etleva Bejko practices Rheumatology Physician in Vista, CA.
Where does Dr. Etleva Bejko practice?
Dr. Etleva Bejko practices at 2023 W Vista Way Ste H, Vista, CA 920836030. Office phone: 7607245800.
What is Dr. Etleva Bejko's NPI?
Dr. Etleva Bejko's National Provider Identifier (NPI) is 1164804431, issued by NPPES.
Does Dr. Etleva Bejko accept Medicare assignment?
Yes. Dr. Etleva Bejko accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Etleva Bejko commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.